Temperature monitoring and viral shedding following BA.1 and VIC01 challenge and rechallenge. by Kathryn A. Ryan (13730701)

Developmental regulation of BLBP-positive radial glia and BrdU-positive proliferative cells in the <i>Xenopus</i> tectum. by Yi Tao (178829)

“…Right panel: a higher magnification image of the right tectum, Scale: 50 μm. …”

SNAP-25 protein concentration in MO3.13. by Simone Agostini (760354)

Presentation_1_Design of Efficient Exciplex Emitters by Decreasing the Energy Gap Between the Local Excited Triplet (3LE) State of the Acceptor and the Charge Transfer (CT) States... by Xiaofang Wei (546822)

“…When we changed the doping concentration of the exciplex from 15% to 50%, the ratio of the triplet decreased, and Φ_PL decreased by half, perhaps due to the increased energy gap between ¹CT and ³LE. …”

Presentation_1_Design of Efficient Exciplex Emitters by Decreasing the Energy Gap Between the Local Excited Triplet (3LE) State of the Acceptor and the Charge Transfer (CT) States... by Xiaofang Wei (546822)

“…When we changed the doping concentration of the exciplex from 15% to 50%, the ratio of the triplet decreased, and Φ_PL decreased by half, perhaps due to the increased energy gap between ¹CT and ³LE. …”

The changes of EFR3A expression in the organ of Corti in the animals treated with kanamycin and furosemide by western blotting. by Chen Nie (686387)

“…<p>TUJ1 protein, with a molecular weight of 50 KD, was identified as an internal reference. …”

Discovery of the Diphenyl 6‑Oxo-1,6-dihydropyridazine-3-carboxylate/carboxamide Analogue J27 for the Treatment of Acute Lung Injury and Sepsis by Targeting JNK2 and Inhibiting the... by Jing Liao (193197)

“…The optimal compound <b>J27</b> decreased the release of TNF-α and IL-6 in mouse and human cells J774A.1 and THP-1 (IL-6 IC₅₀ = 0.22 μM) through the NF-κB/MAPK pathway. …”

Discovery of the Diphenyl 6‑Oxo-1,6-dihydropyridazine-3-carboxylate/carboxamide Analogue J27 for the Treatment of Acute Lung Injury and Sepsis by Targeting JNK2 and Inhibiting the... by Jing Liao (193197)

“…The optimal compound <b>J27</b> decreased the release of TNF-α and IL-6 in mouse and human cells J774A.1 and THP-1 (IL-6 IC₅₀ = 0.22 μM) through the NF-κB/MAPK pathway. …”

The heterogeneity of TAS2R inhibition of [Ca²⁺]_i is recapitulated in HASM physiological responses. by Blanca Camoretti-Mercado (762326)

Effect of therapy with somatostatin analogues (SSAs) on the plasma levels of total-CgA and VS-1 in patients with ileal and pancreatic NENs. by Andrea Corsello (5172026)

TAS2R inhibition of stimulated [Ca²⁺]_i is not dependent on G_i or G_q coupled receptor stimulation. by Blanca Camoretti-Mercado (762326)

Combining RT and αCD47 reduced tumor volume and increased survival rates. by Elham Rostami (339949)

Quantitative effect of TAS2R agonists on [Ca²⁺]_i in HASM stimulated by five GPCR agonists. by Blanca Camoretti-Mercado (762326)

Sema3a inhibits the differentiation of Raw264.7 cells to osteoclasts under 2Gy radiation by reducing inflammation by Bo Huang (30906)

“…Raw264.7 cells were divided into four groups: A, receiving no radiation; B, receiving no radiation + 50ngng/ml Sema3a; C, receiving 2Gy radiation; and D, receiving 2Gy radiation +50ngng/ml Sema3a. …”

The C terminal D0 domain of flagellin is required for TLR5 activation. by Vida Forstnerič (3155814)

“…HEK293 cells were transfected with TLR5 (1 ng) and increasing amounts of SFΔD0-TLR5 (1–25 ng). …”

LPC-DHA affects membrane phospholipid saturation. by Jia Pei Chan (5593388)

“…<p>Targeted lipidomic analysis of NSC^WT and NSC^KO cells treated with or without 50 μM LPC-DHA for 16 hours. (A) NSC^WT cells showed increased DHA in PC, PE, and PS relative to NSC^KO cells. …”

Turn-off and turn-on with hard switching at <i>f</i>_<i>r</i><i>/2</i> < <i>f</i>_<i>SL</i>(50 kHz) < <i>f</i>_<i>r</i> of the switch <i>S</i><sub><i>... by M. Zakir Hossain (6033752)

Protein levels of Bcl-2 family markers in limbal stromal cells (LSCs) and in Aniridia-LSCs (AN-LSCs), after treatment with 0 µM, 50 µM and 75 µM Cobalt chloride (CoCl₂),... by Shanhe Liu (5251313)

Synthesis of Triazole-Substituted Quinazoline Hybrids for Anticancer Activity and a Lead Compound as the EGFR Blocker and ROS Inducer Agent by Biswadip Banerji (482320)

“…A series of triazole-substituted quinazoline hybrid compounds were designed and synthesized for anticancer activity targeting epidermal growth factor receptor (EGFR) tyrosine kinase. …”

4‑Aminoquinoline Antimalarials Containing a Benzyl­methyl­pyridyl­methyl­amine Group Are Active against Drug Resistant <i>Plasmodium falciparum</i> and Exhibit Oral Activity in Mic... by Mukesh C. Joshi (4670284)

“…These compounds exhibited significantly improved solubility and decreased lipophilicity and were potent against chloroquine-sensitive (NF54) and -resistant (Dd2 and 7G8) <i>P. falciparum</i> strains with 5/6 having IC₅₀ < 100 nM against the NF54 strain. …”